NK Cell Therapy Market Growth by Manufactures, Types, Applications and Regions 2018-2025
DecisionMarketReports.com published “Global NK Cell Therapy Market” from its database. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, November 21, 2018 ) Global NK Cell Therapy Market Insights, Forecast to 2025
This report studies the global market size of NK Cell Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of NK Cell Therapy in these regions.
This research report categorizes the global NK Cell Therapy market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
Request a Free PDF Sample Report @ http://decisionmarketreports.com/request-sample?productID=858442
In 2017, the global NK Cell Therapy market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the NK Cell Therapy market based on company, product type, application and key regions.
The various contributors involved in the value chain of NK Cell Therapy include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the NK Cell Therapy include
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)
Market Size Split by Type
Mogamulizumab
Lorvotuzumab Mertansine
Others
Market Size Split by Application
Cancer
Cardiovascular Diseases
Others
Browse Complete Report with Table of Content @ http://decisionmarketreports.com/market-reports/858442/global-nk-cell-therapy-market
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global NK Cell Therapy market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of NK Cell Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global NK Cell Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the NK Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of NK Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of NK Cell Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of NK Cell Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 NK Cell Therapy Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global NK Cell Therapy Market Size Growth Rate by Type
1.4.2 Mogamulizumab
1.4.3 Lorvotuzumab Mertansine
1.4.4 Others
1.5 Market by Application
1.5.1 Global NK Cell Therapy Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Cardiovascular Diseases
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global NK Cell Therapy Market Size
2.1.1 Global NK Cell Therapy Revenue 2016-2025
2.1.2 Global NK Cell Therapy Sales 2016-2025
2.2 NK Cell Therapy Growth Rate by Regions
2.2.1 Global NK Cell Therapy Sales by Regions
2.2.2 Global NK Cell Therapy Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 NK Cell Therapy Sales by Manufacturers
3.1.1 NK Cell Therapy Sales by Manufacturers
3.1.2 NK Cell Therapy Sales Market Share by Manufacturers
3.1.3 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2 NK Cell Therapy Revenue by Manufacturers
3.2.1 NK Cell Therapy Revenue by Manufacturers (2016-2018)
3.2.2 NK Cell Therapy Revenue Share by Manufacturers (2016-2018)
3.3 NK Cell Therapy Price by Manufacturers
3.4 NK Cell Therapy Manufacturing Base Distribution, Product Types
3.4.1 NK Cell Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers NK Cell Therapy Product Category
3.4.3 Date of International Manufacturers Enter into NK Cell Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global NK Cell Therapy Sales by Type
4.2 Global NK Cell Therapy Revenue by Type
4.3 NK Cell Therapy Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global NK Cell Therapy Breakdown Data by Application
6 North America
6.1 North America NK Cell Therapy by Countries
6.1.1 North America NK Cell Therapy Sales by Countries
6.1.2 North America NK Cell Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America NK Cell Therapy by Type
6.3 North America NK Cell Therapy by Application
6.4 North America NK Cell Therapy by Company
7 Europe
7.1 Europe NK Cell Therapy by Countries
7.1.1 Europe NK Cell Therapy Sales by Countries
7.1.2 Europe NK Cell Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe NK Cell Therapy by Type
7.3 Europe NK Cell Therapy by Application
7.4 Europe NK Cell Therapy by Company
8 Asia Pacific
8.1 Asia Pacific NK Cell Therapy by Countries
8.1.1 Asia Pacific NK Cell Therapy Sales by Countries
8.1.2 Asia Pacific NK Cell Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific NK Cell Therapy by Type
8.3 Asia Pacific NK Cell Therapy by Application
8.4 Asia Pacific NK Cell Therapy by Company
9 Central & South America
9.1 Central & South America NK Cell Therapy by Countries
9.1.1 Central & South America NK Cell Therapy Sales by Countries
9.1.2 Central & South America NK Cell Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America NK Cell Therapy by Type
9.3 Central & South America NK Cell Therapy by Application
9.4 Central & South America NK Cell Therapy by Company
10 Middle East and Africa
10.1 Middle East and Africa NK Cell Therapy by Countries
10.1.1 Middle East and Africa NK Cell Therapy Sales by Countries
10.1.2 Middle East and Africa NK Cell Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa NK Cell Therapy by Type
10.3 Middle East and Africa NK Cell Therapy by Application
10.4 Middle East and Africa NK Cell Therapy by Company
11 Company Profiles
11.1 Chipscreen Biosciences (China)
11.1.1 Chipscreen Biosciences (China) Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.1.4 NK Cell Therapy Product Description
11.1.5 Recent Development
11.2 Affimed NV (Netherlands)
11.2.1 Affimed NV (Netherlands) Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.2.4 NK Cell Therapy Product Description
11.2.5 Recent Development
11.3 Altor BioScience Corporation (USA)
11.3.1 Altor BioScience Corporation (USA) Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.3.4 NK Cell Therapy Product Description
11.3.5 Recent Development
11.4 Innate Pharma SA (France)
11.4.1 Innate Pharma SA (France) Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.4.4 NK Cell Therapy Product Description
11.4.5 Recent Development
11.5 Takeda Pharmaceutical (Japan)
11.5.1 Takeda Pharmaceutical (Japan) Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.5.4 NK Cell Therapy Product Description
11.5.5 Recent Development
11.6 Sorrento Therapeutics Inc. (USA)
11.6.1 Sorrento Therapeutics Inc. (USA) Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.6.4 NK Cell Therapy Product Description
11.6.5 Recent Development
11.7 NantKwest Inc. (USA)
11.7.1 NantKwest Inc. (USA) Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.7.4 NK Cell Therapy Product Description
11.7.5 Recent Development
11.8 Bristol-Myers Squibb (USA)
11.8.1 Bristol-Myers Squibb (USA) Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.8.4 NK Cell Therapy Product Description
11.8.5 Recent Development
11.9 NKT Therapeutics (USA)
11.9.1 NKT Therapeutics (USA) Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.9.4 NK Cell Therapy Product Description
11.9.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key NK Cell Therapy Raw Material
13.1.2 NK Cell Therapy Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
This report studies the global market size of NK Cell Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of NK Cell Therapy in these regions.
This research report categorizes the global NK Cell Therapy market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
Request a Free PDF Sample Report @ http://decisionmarketreports.com/request-sample?productID=858442
In 2017, the global NK Cell Therapy market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the NK Cell Therapy market based on company, product type, application and key regions.
The various contributors involved in the value chain of NK Cell Therapy include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the NK Cell Therapy include
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)
Market Size Split by Type
Mogamulizumab
Lorvotuzumab Mertansine
Others
Market Size Split by Application
Cancer
Cardiovascular Diseases
Others
Browse Complete Report with Table of Content @ http://decisionmarketreports.com/market-reports/858442/global-nk-cell-therapy-market
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global NK Cell Therapy market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of NK Cell Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global NK Cell Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the NK Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of NK Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of NK Cell Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of NK Cell Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 NK Cell Therapy Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global NK Cell Therapy Market Size Growth Rate by Type
1.4.2 Mogamulizumab
1.4.3 Lorvotuzumab Mertansine
1.4.4 Others
1.5 Market by Application
1.5.1 Global NK Cell Therapy Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Cardiovascular Diseases
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global NK Cell Therapy Market Size
2.1.1 Global NK Cell Therapy Revenue 2016-2025
2.1.2 Global NK Cell Therapy Sales 2016-2025
2.2 NK Cell Therapy Growth Rate by Regions
2.2.1 Global NK Cell Therapy Sales by Regions
2.2.2 Global NK Cell Therapy Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 NK Cell Therapy Sales by Manufacturers
3.1.1 NK Cell Therapy Sales by Manufacturers
3.1.2 NK Cell Therapy Sales Market Share by Manufacturers
3.1.3 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2 NK Cell Therapy Revenue by Manufacturers
3.2.1 NK Cell Therapy Revenue by Manufacturers (2016-2018)
3.2.2 NK Cell Therapy Revenue Share by Manufacturers (2016-2018)
3.3 NK Cell Therapy Price by Manufacturers
3.4 NK Cell Therapy Manufacturing Base Distribution, Product Types
3.4.1 NK Cell Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers NK Cell Therapy Product Category
3.4.3 Date of International Manufacturers Enter into NK Cell Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global NK Cell Therapy Sales by Type
4.2 Global NK Cell Therapy Revenue by Type
4.3 NK Cell Therapy Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global NK Cell Therapy Breakdown Data by Application
6 North America
6.1 North America NK Cell Therapy by Countries
6.1.1 North America NK Cell Therapy Sales by Countries
6.1.2 North America NK Cell Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America NK Cell Therapy by Type
6.3 North America NK Cell Therapy by Application
6.4 North America NK Cell Therapy by Company
7 Europe
7.1 Europe NK Cell Therapy by Countries
7.1.1 Europe NK Cell Therapy Sales by Countries
7.1.2 Europe NK Cell Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe NK Cell Therapy by Type
7.3 Europe NK Cell Therapy by Application
7.4 Europe NK Cell Therapy by Company
8 Asia Pacific
8.1 Asia Pacific NK Cell Therapy by Countries
8.1.1 Asia Pacific NK Cell Therapy Sales by Countries
8.1.2 Asia Pacific NK Cell Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific NK Cell Therapy by Type
8.3 Asia Pacific NK Cell Therapy by Application
8.4 Asia Pacific NK Cell Therapy by Company
9 Central & South America
9.1 Central & South America NK Cell Therapy by Countries
9.1.1 Central & South America NK Cell Therapy Sales by Countries
9.1.2 Central & South America NK Cell Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America NK Cell Therapy by Type
9.3 Central & South America NK Cell Therapy by Application
9.4 Central & South America NK Cell Therapy by Company
10 Middle East and Africa
10.1 Middle East and Africa NK Cell Therapy by Countries
10.1.1 Middle East and Africa NK Cell Therapy Sales by Countries
10.1.2 Middle East and Africa NK Cell Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa NK Cell Therapy by Type
10.3 Middle East and Africa NK Cell Therapy by Application
10.4 Middle East and Africa NK Cell Therapy by Company
11 Company Profiles
11.1 Chipscreen Biosciences (China)
11.1.1 Chipscreen Biosciences (China) Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.1.4 NK Cell Therapy Product Description
11.1.5 Recent Development
11.2 Affimed NV (Netherlands)
11.2.1 Affimed NV (Netherlands) Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.2.4 NK Cell Therapy Product Description
11.2.5 Recent Development
11.3 Altor BioScience Corporation (USA)
11.3.1 Altor BioScience Corporation (USA) Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.3.4 NK Cell Therapy Product Description
11.3.5 Recent Development
11.4 Innate Pharma SA (France)
11.4.1 Innate Pharma SA (France) Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.4.4 NK Cell Therapy Product Description
11.4.5 Recent Development
11.5 Takeda Pharmaceutical (Japan)
11.5.1 Takeda Pharmaceutical (Japan) Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.5.4 NK Cell Therapy Product Description
11.5.5 Recent Development
11.6 Sorrento Therapeutics Inc. (USA)
11.6.1 Sorrento Therapeutics Inc. (USA) Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.6.4 NK Cell Therapy Product Description
11.6.5 Recent Development
11.7 NantKwest Inc. (USA)
11.7.1 NantKwest Inc. (USA) Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.7.4 NK Cell Therapy Product Description
11.7.5 Recent Development
11.8 Bristol-Myers Squibb (USA)
11.8.1 Bristol-Myers Squibb (USA) Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.8.4 NK Cell Therapy Product Description
11.8.5 Recent Development
11.9 NKT Therapeutics (USA)
11.9.1 NKT Therapeutics (USA) Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of NK Cell Therapy
11.9.4 NK Cell Therapy Product Description
11.9.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key NK Cell Therapy Raw Material
13.1.2 NK Cell Therapy Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Contact Information:
Decision Market Reports
Gasper James
Tel: +1-866-605-1052
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Decision Market Reports
Gasper James
Tel: +1-866-605-1052
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results